ES2119176T3 - Furo(3,2-b)piridinas y tieno(3,2-b)piridinas como inhibidores de la biosintesis de leucotrienos. - Google Patents

Furo(3,2-b)piridinas y tieno(3,2-b)piridinas como inhibidores de la biosintesis de leucotrienos.

Info

Publication number
ES2119176T3
ES2119176T3 ES94908907T ES94908907T ES2119176T3 ES 2119176 T3 ES2119176 T3 ES 2119176T3 ES 94908907 T ES94908907 T ES 94908907T ES 94908907 T ES94908907 T ES 94908907T ES 2119176 T3 ES2119176 T3 ES 2119176T3
Authority
ES
Spain
Prior art keywords
piridinas
inhibitors
biosynthesis
leucotrene
tieno
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES94908907T
Other languages
English (en)
Inventor
Serge Leger
John H Hutchinson
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Merck Frosst Canada and Co
Original Assignee
Merck Frosst Canada and Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck Frosst Canada and Co filed Critical Merck Frosst Canada and Co
Application granted granted Critical
Publication of ES2119176T3 publication Critical patent/ES2119176T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
    • C07D513/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
    • C07D513/04—Ortho-condensed systems

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)

Abstract

LOS COMPUESTOS QUE TIENEN LA FORMULA (I) ACTUAN COMO INHIBIDORES DE LA BIOSINTESIS DE LEUCOTRIENOS. ESTOS COMPUESTOS SON UTILES COMO AGENTES ANTIASMATICOS, ANTIALERGICOS, ANTIINFLAMATORIOS Y CITOPROTECTORES. TAMBIEN SON UTILES PARA EL TRATAMIENTO DE ANGINAS, ESPASMOS CEREBRALES, NEFRITIS AGLOMERULAR, HEPATITIS, ENDOTOXEMIA, UVEITIS Y RECHAZO A ALOINJERTOS Y PARA PREVENIR LA FORMACION DE PLACAS ATEROESCLEROTICAS.
ES94908907T 1993-03-29 1994-03-10 Furo(3,2-b)piridinas y tieno(3,2-b)piridinas como inhibidores de la biosintesis de leucotrienos. Expired - Lifetime ES2119176T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US08/037,862 US5374635A (en) 1993-03-29 1993-03-29 Furo[3,2-b]pyridines and thieno[3,2-b]pyridines as inhibitors of leukotriene biosynthesis

Publications (1)

Publication Number Publication Date
ES2119176T3 true ES2119176T3 (es) 1998-10-01

Family

ID=21896774

Family Applications (1)

Application Number Title Priority Date Filing Date
ES94908907T Expired - Lifetime ES2119176T3 (es) 1993-03-29 1994-03-10 Furo(3,2-b)piridinas y tieno(3,2-b)piridinas como inhibidores de la biosintesis de leucotrienos.

Country Status (9)

Country Link
US (1) US5374635A (es)
EP (1) EP0691972B1 (es)
JP (1) JPH08510723A (es)
AT (1) ATE167865T1 (es)
AU (1) AU683451B2 (es)
CA (1) CA2156262A1 (es)
DE (1) DE69411375T2 (es)
ES (1) ES2119176T3 (es)
WO (1) WO1994022869A1 (es)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8399666B2 (en) * 2005-11-04 2013-03-19 Panmira Pharmaceuticals, Llc 5-lipoxygenase-activating protein (FLAP) inhibitors
US7977359B2 (en) * 2005-11-04 2011-07-12 Amira Pharmaceuticals, Inc. 5-lipdxygenase-activating protein (FLAP) inhibitors
US20070244128A1 (en) * 2005-11-04 2007-10-18 Amira Pharmaceuticals, Inc. 5-lipoxygenase-activating protein (flap) inhibitors
GB2431927B (en) * 2005-11-04 2010-03-17 Amira Pharmaceuticals Inc 5-Lipoxygenase-activating protein (FLAP) inhibitors
US20070219206A1 (en) * 2005-11-04 2007-09-20 Amira Pharmaceuticals, Inc. 5-lipoxygenase-activating protein (flap) inhibitors
TW200920369A (en) * 2007-10-26 2009-05-16 Amira Pharmaceuticals Inc 5-lipoxygenase activating protein (flap) inhibitor
JP5791500B2 (ja) * 2008-05-23 2015-10-07 パンミラ ファーマシューティカルズ，エルエルシー． ５−リポキシゲナーゼ活性化タンパク質阻害剤
US8546431B2 (en) 2008-10-01 2013-10-01 Panmira Pharmaceuticals, Llc 5-lipoxygenase-activating protein (FLAP) inhibitors

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH498831A (fr) * 1967-12-27 1970-11-15 Lodzkie Zaklady Farma Procédé pour la préparation d'acides indolyl-3 acétiques
IT1171624B (it) * 1980-11-12 1987-06-10 Thomae Gmbh Dr K Indolinoni dotati di proprieta' farmaceutiche e procedimento per la loro produzione
CA1241660A (en) * 1984-06-25 1988-09-06 Yvan Guindon Indole-2-alkanoic acids
NO174506B (no) * 1984-10-30 1994-02-07 Usv Pharma Corp Analogifremgangsmaate ved fremstilling av terapeutisk aktive forbindelser
US4839369A (en) * 1985-04-16 1989-06-13 Rorer Pharmaceutical Corporation Aryl and heteroaryl ethers as agents for the treatment of hypersensitive ailments
NZ222878A (en) * 1986-12-17 1991-02-26 Merck Frosst Canada Inc 3-hetero-substituted-n-benzyl-indole derivatives, and pharmaceutical compositions
DE3882732T2 (de) * 1987-02-10 1993-12-02 Abbott Lab Indol, Benzofuran, Benzothiophen enthaltende, Lipoxygenase hemmende Verbindungen.
US5034403A (en) * 1989-06-28 1991-07-23 Hoechst-Roussel Pharmaceuticals Inc. Heteroarylamino-and heteroaryloxypyridinamines and related compounds
NZ234883A (en) * 1989-08-22 1995-01-27 Merck Frosst Canada Inc Quinolin-2-ylmethoxy indole derivatives, preparation and pharmaceutical compositions thereof
PT95690A (pt) * 1989-10-27 1991-09-13 American Home Prod Processo para a preparacao de derivados substituidos de acidos benzoilbenzo-, bifenil- e 2-oxazol-alcanoicos, uteis como inibidores de pla2 e da lipoxigenase
US5021576A (en) * 1989-10-27 1991-06-04 American Home Products Corporation 2-Anilino phenylacetic acid derivatives
PT95692A (pt) * 1989-10-27 1991-09-13 American Home Prod Processo para a preparacao de derivados de acidos indole-,indeno-,piranoindole- e tetra-hidrocarbazole-alcanoicos, ou quais sao uteis como inibidores de pla2 e da lipoxigenase
US5095031A (en) * 1990-08-20 1992-03-10 Abbott Laboratories Indole derivatives which inhibit leukotriene biosynthesis
JPH0764841B2 (ja) * 1990-10-03 1995-07-12 ファイザー製薬株式会社 インドール誘導体およびその用途
US5190968A (en) * 1991-09-30 1993-03-02 Merck Frosst Canada, Inc. (Polycyclic-arylmethoxy) indoles as inhibitors of leukotriene biosynthesis
US5308850A (en) * 1991-09-30 1994-05-03 Merck Frosst Canada, Inc. (Bicyclic-hetero-arylmethoxy)indoles as inhibitors of leukotriene biosynthesis

Also Published As

Publication number Publication date
DE69411375D1 (de) 1998-08-06
DE69411375T2 (de) 1999-02-25
EP0691972A1 (en) 1996-01-17
EP0691972B1 (en) 1998-07-01
WO1994022869A1 (en) 1994-10-13
JPH08510723A (ja) 1996-11-12
CA2156262A1 (en) 1994-10-13
ATE167865T1 (de) 1998-07-15
AU683451B2 (en) 1997-11-13
AU6178794A (en) 1994-10-24
US5374635A (en) 1994-12-20

Similar Documents

Publication Publication Date Title
ZA932533B (en) Fluorinated hydroxyalkylquinoline acids as leukotriene antagonists
LV12187A (lv) Nepiesatinatas hidroksialkiletas hinolina rindas karbonskabes
ES2156961T3 (es) Derivados de bisarilcarbinol como inhibidores de la biosintesis de los leucotrienos.
DE69517821D1 (de) Bisarylcarbinol zimtsäure-derivate zur hemmung leukotriener biosynthese
CA2125824A1 (en) Heteroaryl coumarins as inhibitors of leukotriene biosynthesis
FI920734A0 (fi) Ketosyror innehaollande kinoliner med leukotrienantagonisteffekt.
ES2119176T3 (es) Furo(3,2-b)piridinas y tieno(3,2-b)piridinas como inhibidores de la biosintesis de leucotrienos.
CA2125830A1 (en) Heteroaryl cinnamic acids as inhibitors of leukotriene biosynthesis
AU639612B2 (en) Hydroxyalkylquinoline ether acids as leukotriene antagonists
CA2063955A1 (en) Pyrrolo(1,2-a)indole hydroxylamine derivatives as inhibitors of leukotriene biosynthesis
CA2163244A1 (en) Quinoline derivatives as leukotriene antagonists
CA2061706A1 (en) Pyranylphenyl hydroxyalkylnaphthoic acids as inhibitors of leukotriene biosynthesis
WO1995004741A1 (en) Aza-5,5-fused heterocyclic acids as leukotriene antagonists
MY107767A (en) Fluorinated hydroxyalkylquinoline acids as leukotriene antagonists

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 691972

Country of ref document: ES